Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The study aims to evaluate the efficacy of liver transplantation in the context of non-resectable colorectal liver metastasis. The primary endpoint is the overall survival in this group of patients while the secondary endpoint is the disease-free survival. Patients included in this protocol will be evaluated either for whole or partial liver transplantation from deceased or living donors. Type of different transplantations proposed are as follows: 1. Whole liver graft or partial liver (split) from a deceased donor 2. Partial liver graft retrieved from a deceased donor and orthotopically implanted after having performed a left hepatectomy in the recipient. 3. Partial liver graft retrieved from a deceased donor and heterotopically implanted if total hepatectomy can not be performed. 4. Partial liver graft retrieved from a living donor and orthotopically implanted after having performed total hepatectomy. 5. Partial liver graft retrieved from a living donor and orthotopically implanted after having after having performed a left hepatectomy in the recipient. 6. Partial liver graft retrieved from a living donor and heterotopically implanted if total hepatectomy can not be performed. In cases 2-3-5-6 total hepatectomy of native liver can be secondarily performed after having achieved a proper graft hypertrophy in order to avoid a small for size syndrome
Key Details
Gender
All
Age Range
18 Years - 73 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-04-01
Completion Date
2030-03-30
Last Updated
2022-01-11
Healthy Volunteers
No
Interventions
Liver Transplantation
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
Locations (1)
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Italy